Evolution of the Average Target: Astrana Health, Inc.

Evolution of the Target Price: Astrana Health, Inc.

Changes in Analyst Recommendations: Astrana Health, Inc.

79fa61e9dbc79284e6eff285cc1.uqPJcztHgI8sf_aLH3cBWjbixLHhjPYb144zxDtTuAY.1tL-Nnp20ONZN5S9ey1VaQK3poi3x6dasN9Gmw4k6ln-zZsdcmr5-BQ3uw~30f140f6e54d8ae26b51668dd9dd0bcc
05-14 Truist Securities Adjusts Price Target on Astrana Health to $47 From $38, Maintains Buy Rating MT
03-13 Truist Lifts Price Target on Astrana Health to $38 From $37, Keeps Buy Rating MT
01-06 BofA Adjusts Price Target on Astrana Health to $33 From $40, Maintains Buy Rating MT
12-12 Needham Initiates Astrana Health With Buy Rating, $28 Price Target MT
11-12 Truist Lowers Price Target on Astrana Health to $37 From $46, Keeps Buy Rating MT
25-08-07 Astrana Q2 revenue rises 35% but misses analyst expectations RE
25-04-01 Barclays Initiates Astrana Health at Equalweight With $36 Price Target MT
24-12-16 Macquarie Initiates Astrana Health at Neutral With $41 Price Target MT
24-10-14 TD Cowen Initiates Astrana Health at Buy With $66 Price Target MT
24-10-11 KeyBanc Initiates Astrana Health at Sector Weight MT
24-08-08 Truist Securities Raises Price Target on Astrana Health to $59 From $50, Maintains Buy Rating MT
24-07-11 Top Midday Gainers MT
24-07-11 Astrana Health Shares Rise After Truist Upgrade MT
24-07-11 Truist Upgrades Astrana Health to Buy From Hold, Notes Better Visibility, Underappreciated Tailwinds; Lifts PT to $50 From $44 MT
24-06-27 Stifel Adjusts Price Target on Astrana Health to $48 From $45, Maintains Buy Rating MT
24-05-30 Baird Starts Astrana Health With Outperform Rating, $54 Price Target MT
24-05-08 Stifel Cuts Price Target on Astrana Health to $45 From $50, Maintains Buy Rating MT
24-03-01 Truist Securities Adjusts Price Target on Astrana Health to $44 From $41, Maintains Hold Rating MT
24-02-26 Jefferies Starts Coverage on Apollo Medical With Buy Rating MT
24-01-24 Stifel Starts Coverage on Apollo Medical with Buy Rating, $45 Price Target MT
23-12-22 Truist Initiates Apollo Medical With Hold Rating, Price Target is $41 MT
23-10-17 BTIG Initiates Apollo Medical at Buy Rating With $45 Price Target MT
23-04-12 BofA Securities Initiates Apollo Medical at Neutral With $44 Price Target MT
23-02-27 Lake Street Adjusts Price Target on Apollo Medical Holdings to $60 From $40, Maintains Buy Rating MT
22-12-19 Lake Street Initiates Apollo Medical With Buy Rating, Sets $40 Price Target MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+4.71%
+24.2%
+27.2%
+3.09%
+25%
+22.31%
+42.39%
-10.97%
+1.77%
Average +15.52%
Weighted average by Cap. +13.75%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
40.99USD
Average target price
49.33USD
Spread / Average Target
+20.35%
High Price Target
65.00USD
Spread / Highest target
+58.58%
Low Price Target
41.00USD
Spread / Lowest Target
+0.02%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Truist Securities
BofA Securities
Needham & Co.
Barclays
Macquarie
TD Cowen
KeyBanc Capital Markets
Baird
Stifel Nicolaus
Jefferies & Co.
BTIG
Lake Street
William Blair & Co.
Colliers Securities
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
40.99USD
Average target price
49.33USD
Spread / Average Target
+20.35%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ASTH Stock
  4. 3AM Stock
  5. Consensus Astrana Health, Inc.